BONEH Stock Overview
A biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BBS-Bioactive Bone Substitutes Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.06 |
| 52 Week High | €0.66 |
| 52 Week Low | €0.04 |
| Beta | -0.35 |
| 1 Month Change | 13.96% |
| 3 Month Change | -77.88% |
| 1 Year Change | -87.80% |
| 3 Year Change | -97.61% |
| 5 Year Change | -98.18% |
| Change since IPO | -98.60% |
Recent News & Updates
Recent updates
We Think BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Has A Fair Chunk Of Debt
Sep 16
BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Dec 20BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Is Making Moderate Use Of Debt
Sep 02Is BBS-Bioactive Bone Substitutes Oyj (HEL:BONEH) Using Too Much Debt?
Feb 27Shareholder Returns
| BONEH | FI Biotechs | FI Market | |
|---|---|---|---|
| 7D | -0.3% | 0.8% | 2.2% |
| 1Y | -87.8% | 19.1% | -0.5% |
Return vs Industry: BONEH underperformed the Finnish Biotechs industry which returned 16.9% over the past year.
Return vs Market: BONEH underperformed the Finnish Market which returned -2.7% over the past year.
Price Volatility
| BONEH volatility | |
|---|---|
| BONEH Average Weekly Movement | 23.9% |
| Biotechs Industry Average Movement | 7.8% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FI Market | 8.4% |
| 10% least volatile stocks in FI Market | 2.7% |
Stable Share Price: BONEH's share price has been volatile over the past 3 months compared to the Finnish market.
Volatility Over Time: BONEH's weekly volatility has increased from 15% to 24% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 24 | Juliusz Rakowskias | www.bbs-artebone.fi |
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.
BBS-Bioactive Bone Substitutes Oyj Fundamentals Summary
| BONEH fundamental statistics | |
|---|---|
| Market cap | €1.50m |
| Earnings (TTM) | -€3.56m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.4x
P/E RatioIs BONEH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BONEH income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €15.62k |
| Gross Profit | -€15.62k |
| Other Expenses | €3.54m |
| Earnings | -€3.56m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 21, 2025
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 147.1% |
How did BONEH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 03:32 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BBS-Bioactive Bone Substitutes Oyj is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marianne Palmu | Inderes Oy |
| Antti Siltanen | Inderes Oy |